|
animals |
38 |
|
covid-19 |
36 |
|
humans |
36 |
|
sars-cov-2 |
35 |
|
h5n1 |
32 |
|
adult |
27 |
|
coronavirus |
25 |
|
birds - virology |
24 |
|
phylogeny |
22 |
|
disease outbreaks |
21 |
|
influenza virus |
20 |
|
nasopharyngeal carcinoma |
20 |
|
rna, viral - genetics |
20 |
|
cell line |
19 |
|
china - epidemiology |
19 |
|
female |
19 |
|
influenza |
19 |
|
influenza, human - virology |
19 |
|
china |
18 |
|
evolution, molecular |
18 |
|
hemagglutinin |
18 |
|
influenza in birds - virology |
18 |
|
influenza, human - epidemiology - virology |
18 |
|
molecular sequence data |
18 |
|
cattle |
17 |
|
h1n1 |
17 |
|
hong kong - epidemiology |
17 |
|
mucosal immunity |
17 |
|
transmission |
17 |
|
antigens, viral - analysis |
16 |
|
epstein-barr virus |
16 |
|
genotype |
16 |
|
influenza a virus |
16 |
|
influenza in birds - epidemiology - virology |
16 |
|
viral load |
16 |
|
virus replication |
16 |
|
base sequence |
15 |
|
bat |
15 |
|
live attenuated vaccine |
15 |
|
poultry - virology |
15 |
|
swine - virology |
15 |
|
animal |
14 |
|
avian influenza |
14 |
|
hemagglutination inhibition tests |
14 |
|
human |
14 |
|
influenza a |
14 |
|
influenza a virus, h5n1 subtype - classification - genetics - isolation & purification |
14 |
|
interferon |
14 |
|
mutation - genetics |
14 |
|
sequence analysis, dna |
14 |
|
age |
13 |
|
child |
13 |
|
d222g |
13 |
|
dogs |
13 |
|
h7n9 |
13 |
|
influenza a virus, h1n1 subtype - genetics - pathogenicity |
13 |
|
male |
13 |
|
pandemic |
13 |
|
aged |
12 |
|
antibodies, viral - blood |
12 |
|
cell line, tumor |
12 |
|
mice |
12 |
|
mutation |
12 |
|
sequence homology, amino acid |
12 |
|
serotyping |
12 |
|
2′-o-methyltransferase |
11 |
|
amino acid substitution |
11 |
|
animal cell |
11 |
|
animal tissue |
11 |
|
anthranilic acid |
11 |
|
broad spectrum |
11 |
|
coronavirus disease 2019 |
11 |
|
endoplasmic reticulum |
11 |
|
feces analysis |
11 |
|
genes, viral |
11 |
|
human immunodeficiency virus |
11 |
|
mice, inbred balb c |
11 |
|
molecular epidemiology |
11 |
|
nsp16 |
11 |
|
polymerase chain reaction |
11 |
|
species specificity |
11 |
|
sterilizing immunity |
11 |
|
t-cell response |
11 |
|
transfection |
11 |
|
viral proteins - genetics |
11 |
|
acute hepatitis |
10 |
|
adaptation |
10 |
|
aged, 80 and over |
10 |
|
amino acid sequence |
10 |
|
avian |
10 |
|
biodiversity |
10 |
|
bronchiectasis |
10 |
|
case report |
10 |
|
cell tropism |
10 |
|
chick embryo |
10 |
|
chronic obstructive lung disease |
10 |
|
d225g |
10 |
|
damplicon |
10 |
|
disease outbreaks - prevention & control |
10 |
|
genetic variation |
10 |
|
genome, viral |
10 |
|
hemagglutinin glycoproteins, influenza virus - genetics - metabolism |
10 |
|
incidence |
10 |
|
influenza a virus, h1n1 subtype - physiology |
10 |
|
influenza a virus, h5n1 subtype - physiology |
10 |
|
influenza h1n1 |
10 |
|
influenza, human - immunology - pathology - virology |
10 |
|
middle aged |
10 |
|
novel |
10 |
|
poultry |
10 |
|
prevalence |
10 |
|
sialic acid |
10 |
|
swine diseases - virology |
10 |
|
swine-origin |
10 |
|
temperature |
10 |
|
virus evolution |
10 |
|
airway organoid |
9 |
|
antibodies, viral - biosynthesis |
9 |
|
astroviridae infections - epidemiology - veterinary - virology |
9 |
|
avian influenza virus |
9 |
|
ba.5.2 |
9 |
|
celecoxib |
9 |
|
cell surface |
9 |
|
chiroptera - classification - virology |
9 |
|
chiroptera - virology |
9 |
|
chromatin accessibility |
9 |
|
cohort studies |
9 |
|
coronavac |
9 |
|
coronavirus - classification - genetics - isolation & purification |
9 |
|
cytokines - blood |
9 |
|
ducks - virology |
9 |
|
entry |
9 |
|
fc-rbd |
9 |
|
fluorescent antibody technique, indirect |
9 |
|
genetics |
9 |
|
host-virus interaction |
9 |
|
infectivity |
9 |
|
influenza a virus, h1n1 subtype - classification - genetics - isolation and purification - physiology |
9 |
|
influenza a virus, h1n1 subtype - genetics - isolation and purification - physiology |
9 |
|
influenza a virus, h1n1 subtype - isolation and purification |
9 |
|
influenza, human - diagnosis - virology |
9 |
|
influenza, human - epidemiology - prevention & control - transmission - virology |
9 |
|
internalization |
9 |
|
mamastrovirus - classification - genetics - isolation & purification |
9 |
|
mesalazine |
9 |
|
molecular sequence numbers |
9 |
|
neutralizing antibody |
9 |
|
nucleolin |
9 |
|
omicron variant |
9 |
|
orthomyxoviridae infections - epidemiology - transmission - veterinary - virology |
9 |
|
orthomyxoviridae infections - immunology - mortality - physiopathology - virology |
9 |
|
oseltamivir |
9 |
|
polymorphism, genetic |
9 |
|
proximal differentiation |
9 |
|
sars |
9 |
|
swine - blood - virology |
9 |
|
swine diseases - blood - epidemiology - transmission - virology |
9 |
|
t-lymphocytes - immunology |
9 |
|
tumor microenvironment |
9 |
|
vopba |
9 |
|
whole-genome bisulfite sequencing |
9 |
|
xbb.1 |
9 |
|
young adult |
9 |
|
zanamivir |
9 |
|
a(h3n2) |
8 |
|
adolescent |
8 |
|
age factors |
8 |
|
antibodies, neutralizing - blood |
8 |
|
antibodies, viral - genetics - immunology - metabolism |
8 |
|
antibody |
8 |
|
antibody blood level |
8 |
|
antibody formation |
8 |
|
antibody titer |
8 |
|
asia, southeastern |
8 |
|
avian influenza a virus |
8 |
|
balb/c mice |
8 |
|
betacoronavirus |
8 |
|
biology |
8 |
|
biotechnology technology: comprehensive works medical sciences chemistry |
8 |
|
chemokine |
8 |
|
chicken |
8 |
|
child, preschool |
8 |
|
clade 2.3.4.4b |
8 |
|
clarithromycin |
8 |
|
cricetinae |
8 |
|
cross-reactive |
8 |
|
cytokine |
8 |
|
delns1-ncov-rbd laiv |
8 |
|
dipeptidyl peptidase 4 |
8 |
|
emc |
8 |
|
genes, viral - genetics |
8 |
|
hcov-emc |
8 |
|
hku1 |
8 |
|
hong kong |
8 |
|
hospitalized |
8 |
|
hypsugo bat |
8 |
|
il-8 |
8 |
|
infant |
8 |
|
influenza a virus, h1n1 subtype - genetics |
8 |
|
influenza a virus, h1n1 subtype - genetics - immunology - isolation and purification |
8 |
|
influenza a virus, h1n1 subtype - immunology |
8 |
|
influenza a virus, h1n1 subtype - isolation & purification - pathogenicity |
8 |
|
influenza a virus, h5n1 subtype - isolation & purification - pathogenicity |
8 |
|
influenza in birds - epidemiology - transmission - virology |
8 |
|
influenza vaccines - immunology |
8 |
|
influenza, human - epidemiology - pathology - virology |
8 |
|
influenza, human - immunology |
8 |
|
interferon lambda 1 |
8 |
|
intranasal |
8 |
|
mammary gland |
8 |
|
middle east respiratory syndrome coronavirus |
8 |
|
naproxen |
8 |
|
neutralization |
8 |
|
nucleoprotein |
8 |
|
oc43 |
8 |
|
pa |
8 |
|
pathogenesis |
8 |
|
phase-1 |
8 |
|
positive selection |
8 |
|
recombinant proteins - immunology - metabolism |
8 |
|
sequence homology |
8 |
|
seroprevalence |
8 |
|
severity of illness index |
8 |
|
spike glycoprotein |
8 |
|
spike mutant |
8 |
|
spike s1/s2 mutant |
8 |
|
susceptibility |
8 |
|
time factors |
8 |
|
angiogenesis |
7 |
|
animals, wild - virology |
7 |
|
antibodies, monoclonal - immunology |
7 |
|
antigenic variation |
7 |
|
avian influenza a/h7n9 virus |
7 |
|
bayes theorem |
7 |
|
bird diseases - epidemiology - virology |
7 |
|
cardiac infection |
7 |
|
cardiomyocytes |
7 |
|
cell transformation, neoplastic |
7 |
|
chemicals and cas registry numbers |
7 |
|
cluster analysis |
7 |
|
coinfection |
7 |
|
community-acquired-infections-epidemiology |
7 |
|
community-acquired-infections-mortality |
7 |
|
community-acquired-infections-physiopathology |
7 |
|
community-acquired-infections-virology |
7 |
|
coronavirus - classification - enzymology - genetics - isolation & purification |
7 |
|
coronavirus - classification - genetics - immunology - metabolism |
7 |
|
coronavirus hku1 |
7 |
|
coronavirus-genetics |
7 |
|
cyclin d1 - genetics - metabolism |
7 |
|
defective interfering viral genome |
7 |
|
disease outbreaks - history |
7 |
|
disease outbreaks - statistics & numerical data |
7 |
|
dna, viral - genetics |
7 |
|
ebv serology |
7 |
|
episome |
7 |
|
epstein-barr virus infections - complications - genetics - metabolism - virology |
7 |
|
felidae - virology |
7 |
|
fluorescein-5-isothiocyanate - metabolism |
7 |
|
fluorescent dyes - metabolism |
7 |
|
furin cleavage prra motif |
7 |
|
furin inhibitor |
7 |
|
glycoprotein |
7 |
|
glycosylation |
7 |
|
heart |
7 |
|
hemagglutinins - genetics |
7 |
|
herpesvirus 4, human - genetics - pathogenicity |
7 |
|
history, 20th century |
7 |
|
history, 21st century |
7 |
|
illumina sequencing |
7 |
|
immunization |
7 |
|
immunohistochemistry |
7 |
|
influenza a virus - classification - genetics - isolation & purification |
7 |
|
influenza a virus - genetics |
7 |
|
influenza a virus, h5n1 subtype - classification - genetics - isolation & purification - pathogenicity |
7 |
|
influenza a virus, h9n2 subtype - classification - genetics - isolation and purification |
7 |
|
influenza, human - epidemiology - history |
7 |
|
kidney - cytology |
7 |
|
life cycle |
7 |
|
maturation |
7 |
|
membrane glycoproteins - genetics - immunology - metabolism |
7 |
|
mmp19 |
7 |
|
models, genetic |
7 |
|
molecular clock |
7 |
|
monoinfection |
7 |
|
mustelidae - virology |
7 |
|
nasopharynx - metabolism - pathology - virology |
7 |
|
native conformation |
7 |
|
nglycosylation |
7 |
|
omicron |
7 |
|
physiological processes - genetics |
7 |
|
reassortant |
7 |
|
reassortant viruses - classification - genetics - isolation & purification |
7 |
|
rna helicases - genetics |
7 |
|
rna replicase - genetics |
7 |
|
seasons |
7 |
|
seroepidemiology |
7 |
|
severe acute respiratory syndrome - epidemiology - history - virology |
7 |
|
single molecule real time sequencing |
7 |
|
small-molecule inhibitor |
7 |
|
spike |
7 |
|
surface expression |
7 |
|
swine |
7 |
|
tumor suppressor gene |
7 |
|
viral envelope proteins - genetics - immunology - metabolism |
7 |
|
viral persistence |
7 |
|
viral variants |
7 |
|
virus maturation |
7 |
|
viverridae - virology |
7 |
|
amantadine-pharmacology |
6 |
|
antigen |
6 |
|
antigens, viral - genetics |
6 |
|
antiviral |
6 |
|
binding sites |
6 |
|
biodiversity conservation |
6 |
|
brain |
6 |
|
broad-spectrum |
6 |
|
cats |
6 |
|
chickens - immunology |
6 |
|
co-evolution |
6 |
|
common marmoset |
6 |
|
conservation of natural resources |
6 |
|
coronaviridae - classification - genetics - isolation & purification - physiology |
6 |
|
coronaviridae infections - transmission - veterinary - virology |
6 |
|
detection |
6 |
|
diagnosis, differential |
6 |
|
disease reservoirs - veterinary - virology |
6 |
|
disease reservoirs - virology |
6 |
|
diverse |
6 |
|
dna, viral - classification - genetics |
6 |
|
drug-resistance,-viral-genetics |
6 |
|
ducks - immunology |
6 |
|
ecosystem |
6 |
|
elisa |
6 |
|
far east - epidemiology |
6 |
|
geese - immunology |
6 |
|
guanosine |
6 |
|
guidelines as topic |
6 |
|
hemagglutinin glycoproteins, influenza virus - chemistry - genetics |
6 |
|
hemagglutinin glycoproteins, influenza virus - genetics |
6 |
|
hemagglutinin glycoproteins, influenza virus - genetics - immunology |
6 |
|
hemagglutinins, viral - metabolism |
6 |
|
hepatitis e |
6 |
|
hev-c1 |
6 |
|
host-targeted antiviral |
6 |
|
influenza a virus, h1n1 subtype - genetics - immunology |
6 |
|
influenza a virus, h1n1 subtype - metabolism |
6 |
|
influenza a virus, h5n1 subtype - classification - genetics |
6 |
|
influenza a virus, h5n1 subtype - genetics - immunology - isolation & purification - pathogenicity |
6 |
|
influenza a virus, h5n1 subtype - immunology - isolation & purification |
6 |
|
influenza a virus, h9n2 subtype - chemistry - classification |
6 |
|
influenza a virus, h9n2 subtype - genetics - immunology |
6 |
|
influenza in birds - diagnosis - genetics - virology |
6 |
|
influenza in birds - immunology - prevention & control |
6 |
|
influenza vaccines - administration & dosage |
6 |
|
influenza, human - diagnosis - genetics - virology |
6 |
|
influenza, human - epidemiology - transmission - virology |
6 |
|
influenza-a-virus,-h5n1-subtype-drug-effects |
6 |
|
influenza-a-virus,-h5n1-subtype-genetics |
6 |
|
interspecies |
6 |
|
kaletra |
6 |
|
live-attenuated influenza-based vaccine |
6 |
|
lopinavir |
6 |
|
mers |
6 |
|
mers coronavirus |
6 |
|
middle east |
6 |
|
molecular diagnostic techniques - methods |
6 |
|
mycophenolate |
6 |
|
mycophenolic acid |
6 |
|
nasal prevention |
6 |
|
neuraminidase - genetics |
6 |
|
newly-weaned hamster |
6 |
|
ns1 |
6 |
|
nucleocapsid proteins - genetics |
6 |
|
orthomyxoviridae - genetics - isolation & purification - pathogenicity |
6 |
|
orthomyxoviridae infections - transmission - veterinary - virology |
6 |
|
orthomyxoviridae infections - transmission - virology |
6 |
|
owston's civet |
6 |
|
parvovirus |
6 |
|
pb2 |
6 |
|
pd1-based dna vaccine |
6 |
|
pneumonia - diagnosis - veterinary - virology |
6 |
|
polymerase inhibitor |
6 |
|
poultry diseases - epidemiology - virology |
6 |
|
poultry diseases - prevention & control |
6 |
|
primate |
6 |
|
quarantine - veterinary |
6 |
|
rat hepatitis e |
6 |
|
reassortant viruses - genetics - isolation & purification - pathogenicity |
6 |
|
receptor binding domain |
6 |
|
rectum - virology |
6 |
|
respiratory virus |
6 |
|
ribavirin |
6 |
|
rimantadine-pharmacology |
6 |
|
selection, genetic |
6 |
|
structural evolution |
6 |
|
treatment |
6 |
|
vaccination - veterinary |
6 |
|
viral hepatitis |
6 |
|
viremia - diagnosis - epidemiology |
6 |
|
virology - methods |
6 |
|
virulence |
6 |
|
viverrid |
6 |
|
viverridae - anatomy & histology - physiology - virology |
6 |
|
wild species infections |
6 |
|
zoonosis |
6 |
|
alveolar-bronchiolization |
5 |
|
amino acid motifs |
5 |
|
animal migration |
5 |
|
antiviral agents - pharmacology |
5 |
|
antiviral response |
5 |
|
avian influenza virus h5n1 clade 2.3.4.4b |
5 |
|
basal cell |
5 |
|
birds |
5 |
|
birds - physiology - virology |
5 |
|
broad-spectrum antivirals |
5 |
|
communicable diseases, emerging - epidemiology - immunology |
5 |
|
consensus primers |
5 |
|
consensus sequence |
5 |
|
coronavirus - genetics - isolation & purification |
5 |
|
coronavirus infections - veterinary - virology |
5 |
|
dna primers |
5 |
|
drug resistance, viral |
5 |
|
ducks - genetics - virology |
5 |
|
elderly |
5 |
|
epstein–barr virus infection |
5 |
|
esptein-barr virus |
5 |
|
h7n9 virus |
5 |
|
hamster |
5 |
|
hemagglutinin glycoproteins, influenza virus - classification - genetics |
5 |
|
immune imprinting |
5 |
|
inflammasome activation |
5 |
|
influenza a virus - classification - enzymology - genetics |
5 |
|
influenza a virus - classification - genetics - isolation and purification - pathogenicity |
5 |
|
influenza a virus - classification - genetics - pathogenicity |
5 |
|
influenza a virus - classification - isolation and purification |
5 |
|
influenza a virus, h1n1 subtype - classification - immunology |
5 |
|
influenza a virus, h3n2 subtype - genetics - isolation and purification |
5 |
|
influenza a virus, h5n1 subtype - genetics |
5 |
|
influenza a virus, h5n1 subtype - genetics - isolation & purification |
5 |
|
influenza a virus, h7n9 subtype - genetics - isolation and purification |
5 |
|
influenza a virus, h9n2 subtype - classification - genetics - isolation & purification |
5 |
|
influenza in birds - epidemiology - genetics |
5 |
|
influenza, human - epidemiology - immunology |
5 |
|
influenza, human - transmission - virology |
5 |
|
invadopodia |
5 |
|
invasion |
5 |
|
latent membrane protein 1 |
5 |
|
live-cell imaging |
5 |
|
long covid-19 |
5 |
|
mavs |
5 |
|
mitochondria |
5 |
|
nasopharyngeal epithelial carcinoma |
5 |
|
neutralization tests |
5 |
|
nlrp3 |
5 |
|
oseltamivir - pharmacology |
5 |
|
pasc |
5 |
|
pb1 |
5 |
|
pb1-f2 virulence factor |
5 |
|
phylogenetic tree |
5 |
|
point-of-care systems |
5 |
|
polymerase chain reaction - methods |
5 |
|
polymerase genes |
5 |
|
premalignant nasopharyngeal epithelium |
5 |
|
pyrimidine synthesis inhibitor |
5 |
|
quail - virology |
5 |
|
reassortant viruses - classification - genetics - isolation and purification |
5 |
|
reassortant viruses - classification - genetics - isolation and purification - pathogenicity |
5 |
|
respiratory tract infections |
5 |
|
reverse transcriptase polymerase chain reaction - methods |
5 |
|
rig-i |
5 |
|
rna replicase - chemistry - genetics |
5 |
|
serosurveillance |
5 |
|
tumor-associated macrophage |
5 |
|
viral proteins - chemistry - genetics |
5 |
|
wireless sensor networks |
5 |
|
animals, domestic - virology |
4 |
|
animals, wild |
4 |
|
antibodies |
4 |
|
antigens, viral - classification - genetics - immunology |
4 |
|
asia - epidemiology |
4 |
|
asia, southeastern - epidemiology |
4 |
|
astrocytes - virology |
4 |
|
bird diseases - epidemiology - transmission - virology |
4 |
|
blotting, western |
4 |
|
bronchi - metabolism - virology |
4 |
|
cell differentiation |
4 |
|
charadriiformes - physiology - virology |
4 |
|
chemistry |
4 |
|
chickens - virology |
4 |
|
chimpanzee adenovirus vector |
4 |
|
circulating tumor cells |
4 |
|
clinical |
4 |
|
cross reactions |
4 |
|
ct dna |
4 |
|
diagnosis |
4 |
|
dice1 tumor suppressor |
4 |
|
down-regulation |
4 |
|
ebv |
4 |
|
ebv bart mirnas |
4 |
|
ebv-encoded micrornas |
4 |
|
ecology |
4 |
|
epstein-barr virus (ebv) |
4 |
|
epstein-barr virus infections - complications - metabolism |
4 |
|
evolution |
4 |
|
geese - physiology - virology |
4 |
|
gene pool |
4 |
|
gene silencing |
4 |
|
h10n8 |
4 |
|
h5n1 subtype |
4 |
|
hemagglutinins, viral - classification - genetics - immunology |
4 |
|
herpesvirus 4, human |
4 |
|
highly pathogenic avian influenza |
4 |
|
histopathology |
4 |
|
human infection |
4 |
|
influenza a virus - isolation and purification |
4 |
|
influenza a virus - physiology |
4 |
|
influenza a virus, h1n1 subtype - drug effects |
4 |
|
influenza a virus, h1n1 subtype - pathogenicity |
4 |
|
influenza a virus, h1n2 subtype - pathogenicity |
4 |
|
influenza a virus, h5n1 subtype - genetics - immunology |
4 |
|
influenza a virus, h5n1 subtype - genetics - physiology |
4 |
|
influenza a virus, h5n1 subtype - isolation and purification |
4 |
|
influenza a virus, h5n1 subtype - pathogenicity |
4 |
|
influenza a virus, h7n9 subtype - immunology - isolation and purification |
4 |
|
influenza a virus, h7n9 subtype - isolation and purification |
4 |
|
influenza in birds - epidemiology - transmission |
4 |
|
influenza vaccines |
4 |
|
influenza vaccines - genetics - immunology |
4 |
|
influenza, human - blood - pathology - virology |
4 |
|
influenza, human - epidemiology - immunology - virology |
4 |
|
influenza, human - epidemiology - prevention and control - transmission - virology |
4 |
|
influenza, human - epidemiology - transmission - veterinary - virology |
4 |
|
influenza, human - metabolism - virology |
4 |
|
influenza, human - pathology - physiopathology - virology |
4 |
|
introns |
4 |
|
kuwait - epidemiology |
4 |
|
l336m |
4 |
|
laos - epidemiology |
4 |
|
lysine - genetics |
4 |
|
methylation |
4 |
|
micrornas - genetics - metabolism |
4 |
|
migratory ducks |
4 |
|
nasopharyngeal neoplasms - virology |
4 |
|
nasopharynx - virology |
4 |
|
neuraminidase - antagonists & inhibitors - genetics |
4 |
|
ngs analysis |
4 |
|
nuclear factor 90 proteins - chemistry - genetics - metabolism |
4 |
|
nucleoproteins - genetics - metabolism |
4 |
|
occupational exposure |
4 |
|
orthomyxoviridae infections - transmission |
4 |
|
pathogenicity |
4 |
|
pb2 627 residue |
4 |
|
plasma ebv dna |
4 |
|
point mutation |
4 |
|
poultry workers |
4 |
|
prospective studies |
4 |
|
protective immunity |
4 |
|
protein conformation |
4 |
|
receptors, cell surface - metabolism |
4 |
|
sars-cov-2 vaccine |
4 |
|
sentinel ducks |
4 |
|
serological surveillance |
4 |
|
single-dose immunization |
4 |
|
spike protein |
4 |
|
telomere length |
4 |
|
temperature-sensitivity |
4 |
|
tissue tropism |
4 |
|
viral proteins |
4 |
|
virulence - genetics |
4 |
|
virus interactions |
4 |
|
virus latency |
4 |
|
zoonoses |
4 |
|
antibodies, monoclonal |
3 |
|
antibodies, viral - blood - immunology |
3 |
|
antigens, viral - immunology |
3 |
|
asia |
3 |
|
avian influenza a h9n2 |
3 |
|
bart |
3 |
|
biological markers |
3 |
|
biology of infection |
3 |
|
biomarker |
3 |
|
bird diseases - virology |
3 |
|
body weight |
3 |
|
bone marrow transplantation |
3 |
|
bone marrow transplantation - adverse effects |
3 |
|
carcinoma - diagnosis - epidemiology - immunology - virology |
3 |
|
carcinoma, squamous cell - pathology - virology |
3 |
|
chick embryo - virology |
3 |
|
conserved sequence |
3 |
|
disease outbreaks - prevention & control - veterinary |
3 |
|
dna-binding proteins - immunology |
3 |
|
drug resistance, viral - genetics |
3 |
|
ebv bart |
3 |
|
ebv expression |
3 |
|
enzyme-linked immunosorbent assay |
3 |
|
epigenetics |
3 |
|
epithelial cells |
3 |
|
epitopes - immunology |
3 |
|
epstein-barr virus infections - epidemiology - immunology |
3 |
|
epstein-barr virus nuclear antigens - immunology |
3 |
|
europe |
3 |
|
food microbiology |
3 |
|
h275y |
3 |
|
herpesvirus 4, human - genetics |
3 |
|
herpesvirus 4, human - genetics - immunology - physiology |
3 |
|
herpesvirus 4, human - immunology |
3 |
|
hpai |
3 |
|
immunocompromised host |
3 |
|
immunoglobulin a - blood - immunology |
3 |
|
immunoglobulin g - blood |
3 |
|
immunoglobulin g - blood - immunology |
3 |
|
immunoglobulin m - blood |
3 |
|
in situ hybridization |
3 |
|
influenza a virus - pathogenicity |
3 |
|
influenza a virus, h1n1 subtype - drug effects - genetics - immunology |
3 |
|
influenza a virus, h5n1 subtype |
3 |
|
influenza a virus, h5n1 subtype - classification - genetics - immunology - isolation & purification |
3 |
|
influenza a virus, h5n1 subtype - genetics - immunology - pathogenicity - physiology |
3 |
|
influenza a virus, h5n1 subtype - immunology |
3 |
|
influenza a virus, h7n7 subtype - classification - genetics |
3 |
|
influenza a virus, h9n2 subtype - immunology |
3 |
|
influenza in birds - epidemiology - prevention & control - transmission - virology |
3 |
|
influenza in birds - genetics |
3 |
|
influenza in birds - immunology |
3 |
|
influenza vaccines - immunology - supply & distribution |
3 |
|
influenza vaccines - therapeutic use |
3 |
|
influenza, human - complications - diagnosis - pathology - virology |
3 |
|
influenza, human - immunology - mortality - pathology |
3 |
|
lncrna |
3 |
|
membrane glycoproteins - genetics |
3 |
|
mice, inbred balb/c |
3 |
|
microrna |
3 |
|
nasopharyngeal neoplasms - diagnosis - epidemiology - immunology - virology |
3 |
|
nasopharyngeal neoplasms - pathology - virology |
3 |
|
neuraminidase |
3 |
|
neuraminidase - genetics - immunology - metabolism |
3 |
|
npc |
3 |
|
npc diagnosis |
3 |
|
npc differentiation |
3 |
|
npc risk |
3 |
|
nuclear localization signal |
3 |
|
odds ratio |
3 |
|
orthomyxoviridae infections - immunology |
3 |
|
poultry diseases - virology |
3 |
|
resistance |
3 |
|
respiratory insufficiency - diagnosis - etiology |
3 |
|
restaurants |
3 |
|
risk |
3 |
|
sars virus - genetics - isolation & purification |
3 |
|
saα2,3gal linkage |
3 |
|
saα2,6gal linkage |
3 |
|
sensitivity and specificity |
3 |
|
seroepidemiologic studies |
3 |
|
severe acute respiratory syndrome - blood - epidemiology - transmission - virology |
3 |
|
sialic acid receptors |
3 |
|
trachea - virology |
3 |
|
trans-activators - immunology |
3 |
|
transcription, genetic |
3 |
|
viral envelope proteins - genetics |
3 |
|
viral matrix proteins - analysis |
3 |
|
viral proteins - genetics - immunology - metabolism |
3 |
|
adamantane - therapeutic use |
2 |
|
adaptationautophagy |
2 |
|
agrobacterium rhizogenes |
2 |
|
androstenedione - metabolism |
2 |
|
androsterone - metabolism |
2 |
|
animal model |
2 |
|
anti-h5 monoclonal antibody |
2 |
|
antibodies, viral - immunology |
2 |
|
antibody specificity - immunology |
2 |
|
antigenic cluster |
2 |
|
antigenic dendrogram |
2 |
|
antigens, viral - chemistry - immunology |
2 |
|
antiviral agents - therapeutic use |
2 |
|
avian influenza virus h5n1 |
2 |
|
avian metapneumovirus |
2 |
|
biological sciences |
2 |
|
brd4 |
2 |
|
capsid proteins |
2 |
|
chicken anemia virus |
2 |
|
chicken anemia virus - classification - genetics |
2 |
|
chickens |
2 |
|
chromatin |
2 |
|
circoviridae infections - epidemiology - veterinary - virology |
2 |
|
commerce |
2 |
|
cross species transmission |
2 |
|
cross-protection |
2 |
|
cytoplasmic granules - metabolism |
2 |
|
deoxyribonuclease bamhi - metabolism |
2 |
|
disease models, animal |
2 |
|
dna primers - genetics |
2 |
|
dot elisa |
2 |
|
dot-elisa |
2 |
|
drug sensitivity |
2 |
|
ebna1 |
2 |
|
ebv copy number |
2 |
|
ebv lncbarts |
2 |
|
electrophoresis, polyacrylamide gel |
2 |
|
enzyme-linked immunosorbent assay - methods |
2 |
|
enzyme-linked immunosorbent assay - methods - statistics & numerical data |
2 |
|
epidermal growth factor receptor |
2 |
|
epstein-barr virus infections - diagnosis - immunology |
2 |
|
ferret |
2 |
|
ferrets |
2 |
|
ferrets - virology |
2 |
|
fishes - blood |
2 |
|
fishes - growth & development |
2 |
|
fishes - physiology |
2 |
|
gefitinib |
2 |
|
gene expression |
2 |
|
gene expression regulation |
2 |
|
gonadal steroid hormones - blood |
2 |
|
gonadotropin-releasing hormone - analogs & derivatives - pharmacology |
2 |
|
gonadotropin-releasing hormone - analogs & derivatives - pharmacology - physiology |
2 |
|
gonadotropins - physiology |
2 |
|
gonads - anatomy & histology - drug effects - growth & development |
2 |
|
gonads - metabolism |
2 |
|
h5n1 avian influenza virus |
2 |
|
haemagglutination |
2 |
|
hairy roots |
2 |
|
head and neck cancer |
2 |
|
hemagglutinins, viral - chemistry - genetics - immunology |
2 |
|
hemagglution inhibition |
2 |
|
hepatitis virus |
2 |
|
hermaphroditic organisms |
2 |
|
herpesvirus 4, human - genetics - immunology |
2 |
|
hierarchical clustering |
2 |
|
high pathogenic avian influenza virus |
2 |
|
highly pathogenic avian influenza virus |
2 |
|
human monoclonal antibody |
2 |
|
human-to-human transmission |
2 |
|
in vivo protection |
2 |
|
infection |
2 |
|
inflammation |
2 |
|
influenza a virus - drug effects - immunology |
2 |
|
influenza a virus, h1n1 subtype - genetics - immunology - physiology |
2 |
|
influenza a virus, h1n1 subtype - metabolism - physiology |
2 |
|
influenza a virus, h5n1 subtype - drug effects - genetics - immunology - metabolism |
2 |
|
influenza a virus, h5n1 subtype - immunology - isolation and purification |
2 |
|
influenza in birds - diagnosis |
2 |
|
influenza in birds - diagnosis - virology |
2 |
|
influenza in birds - immunology - virology |
2 |
|
influenza in birds - transmission - virology |
2 |
|
influenza vaccine |
2 |
|
influenza vaccines - administration and dosage - genetics - immunology |
2 |
|
influenza viruses |
2 |
|
influenza, human - drug therapy - prevention & control |
2 |
|
influenza, human - epidemiology - immunology - prevention and control |
2 |
|
influenza, human - immunology - prevention and control - virology |
2 |
|
interferon-alpha - administration and dosage - immunology |
2 |
|
lamiaceae |
2 |
|
leydig cells - drug effects - metabolism |
2 |
|
lithospermic acid b |
2 |
|
live birds markets |
2 |
|
luteinizing hormone - pharmacology |
2 |
|
mass spectrometric sequencing |
2 |
|
metapneumovirus - classification - genetics |
2 |
|
microbiology |
2 |
|
mixed infection |
2 |
|
monoclonal antibodies |
2 |
|
monoclonal antibody |
2 |
|
neuraminidase - immunology |
2 |
|
neutralization test |
2 |
|
newly emerging h5 viruses |
2 |
|
nf-κb |
2 |
|
nigeria |
2 |
|
oligodeoxyribonucleotides - administration and dosage - immunology |
2 |
|
oncogenesis |
2 |
|
organ specificity |
2 |
|
orthomyxoviridae infections - epidemiology - immunology - prevention and control |
2 |
|
paramyxoviridae infections - veterinary |
2 |
|
pathology |
2 |
|
peptide mimic |
2 |
|
peramivir |
2 |
|
point of care |
2 |
|
polymorphism of viral antigen |
2 |
|
poultry diseases - diagnosis - virology |
2 |
|
promoter regions, genetic |
2 |
|
proteins - genetics - metabolism |
2 |
|
rapid test |
2 |
|
receptor |
2 |
|
repetitive sequences, nucleic acid |
2 |
|
replication and transcription |
2 |
|
reproduction - drug effects |
2 |
|
rhesus monkey |
2 |
|
ribonucleoproteins - genetics - metabolism |
2 |
|
rosmarinic acid |
2 |
|
salvia miltiorrhiza |
2 |
|
sequence analysis, dna - veterinary |
2 |
|
sex determination processes |
2 |
|
sex differentiation - drug effects |
2 |
|
sex differentiation - physiology |
2 |
|
sheep |
2 |
|
single-chain antibodies - genetics - immunology - metabolism |
2 |
|
single-chain fragment |
2 |
|
steroids - biosynthesis |
2 |
|
steroids - blood |
2 |
|
testosterone - analogs & derivatives - metabolism |
2 |
|
topoisomerase |
2 |
|
triptorelin pamoate - analogs & derivatives |
2 |
|
tumor cells, cultured |
2 |
|
turkeys |
2 |
|
viral nonstructural proteins - metabolism |
2 |
|
virology |
2 |
|
virus replication - genetics |
2 |
|
virus replication - physiology |
2 |
|
'hit and run' |
1 |
|
3t3 cells |
1 |
|
a (h1n1) influenza |
1 |
|
ace2 |
1 |
|
active transport, cell nucleus |
1 |
|
adenocarcinoma - blood - pathology - therapy |
1 |
|
adenoviridae - genetics |
1 |
|
adenoviruses, human |
1 |
|
adjuvant vaccine |
1 |
|
ags cell line |
1 |
|
animal challenge |
1 |
|
animal models |
1 |
|
antibodies, monoclonal - chemistry - immunology - therapeutic use |
1 |
|
antibodies, monoclonal - genetics - immunology - therapeutic use |
1 |
|
antibodies, neutralizing - genetics - immunology - therapeutic use |
1 |
|
antibodies, viral - chemistry - immunology - therapeutic use |
1 |
|
antibodies, viral - genetics - immunology - therapeutic use |
1 |
|
antibody profile |
1 |
|
antigens, cd - analysis |
1 |
|
antigens, cd19 - analysis |
1 |
|
antigens, viral - biosynthesis - genetics |
1 |
|
antigens, viral - genetics - metabolism |
1 |
|
antineoplastic combined chemotherapy protocols - therapeutic use |
1 |
|
antiviral agents - immunology - therapeutic use |
1 |
|
aptamers |
1 |
|
avian influenza h9n2 virus |
1 |
|
avian influenza virus (h9n2) |
1 |
|
b-lymphocytes |
1 |
|
b-lymphocytes - immunology - virology |
1 |
|
b-lymphocytes - microbiology |
1 |
|
basic-leucine zipper transcription factors |
1 |
|
binary logistic regression |
1 |
|
binding sites - genetics |
1 |
|
binding sites, antibody |
1 |
|
blotting, northern |
1 |
|
border screening |
1 |
|
breast neoplasms - virology |
1 |
|
broad-specific neutralization |
1 |
|
broad-spectrum neutralization |
1 |
|
broadly neutralizing antibodies |
1 |
|
burkitt lymphoma |
1 |
|
burkitt lymphoma - genetics |
1 |
|
callithrix |
1 |
|
carrier proteins - genetics - metabolism |
1 |
|
ccaat-enhancer-binding protein-alpha - genetics - metabolism |
1 |
|
ccaat-enhancer-binding protein-alpha - metabolism |
1 |
|
ccaat-enhancer-binding proteins - genetics - metabolism |
1 |
|
cell biology |
1 |
|
cell cycle - physiology |
1 |
|
cell division |
1 |
|
cell growth |
1 |
|
cell line, transformed |
1 |
|
cell transformation, viral |
1 |
|
cells, cultured |
1 |
|
chloramphenicol o-acetyltransferase - genetics |
1 |
|
cho cells |
1 |
|
cholesterol - metabolism |
1 |
|
chromosomal instability |
1 |
|
chromosomes - ultrastructure |
1 |
|
clinical outcomes |
1 |
|
clone cells |
1 |
|
cloning, molecular |
1 |
|
combined modality therapy |
1 |
|
crispr-cas12a |
1 |
|
cyclin-dependent kinase inhibitor p21 |
1 |
|
cyclins - genetics - metabolism |
1 |
|
cyclins - metabolism |
1 |
|
cytokeratin |
1 |
|
cytokines/chemokines |
1 |
|
cytoplasm - metabolism |
1 |
|
cytoplasmic actin |
1 |
|
cytoskeleton - metabolism |
1 |
|
deoxyribonuclease bamhi |
1 |
|
dna mutational analysis |
1 |
|
dna, viral |
1 |
|
dna, viral - analysis |
1 |
|
dna-binding proteins - biosynthesis - genetics |
1 |
|
dna-binding proteins - chemistry - genetics - metabolism |
1 |
|
dna-binding proteins - genetics - metabolism |
1 |
|
dna-binding proteins - metabolism |
1 |
|
double minute chromosomes (dms) |
1 |
|
ebv-mir-bart8-3p |
1 |
|
electrophoretic mobility shift assay |
1 |
|
elispot |
1 |
|
epithelial cells - cytology - ultrastructure - virology |
1 |
|
epithelial cells - metabolism - virology |
1 |
|
epithelial-mesenchymal transition |
1 |
|
epitope mapping |
1 |
|
epitranscriptomics |
1 |
|
epstein-barr virus nuclear antigens - biosynthesis - genetics |
1 |
|
epstein-barr virus nuclear antigens - genetics |
1 |
|
epstein-barr virus nuclear antigens - genetics - metabolism |
1 |
|
epstein–barr virus |
1 |
|
erk1/2 signaling |
1 |
|
fatty acids - metabolism |
1 |
|
feedback |
1 |
|
fibroblasts - cytology |
1 |
|
fluorescent antibody technique |
1 |
|
g1 phase |
1 |
|
gc/ms |
1 |
|
gene amplification |
1 |
|
gene expression profiling - methods |
1 |
|
gene expression regulation, viral |
1 |
|
genes, reporter |
1 |
|
genetic vectors |
1 |
|
genome alignment |
1 |
|
gold nanoparticles |
1 |
|
h5n1 virus |
1 |
|
h7n9 influenza virus |
1 |
|
h7n9 seed strain |
1 |
|
h7n9 vaccine |
1 |
|
h9n2 |
1 |
|
ha antigenic drift |
1 |
|
ha epitope sb |
1 |
|
haemagglutinin |
1 |
|
hela cells |
1 |
|
hemagglutinin glycoproteins, influenza virus - diagnostic use - immunology |
1 |
|
herpesvirus 4, human - genetics - isolation & purification - pathogenicity - physiology |
1 |
|
herpesvirus 4, human - genetics - metabolism |
1 |
|
herpesvirus 4, human - genetics - metabolism - pathogenicity |
1 |
|
herpesvirus 4, human - genetics - physiology |
1 |
|
herpesvirus 4, human - physiology |
1 |
|
herpesvirus 8, human - drug effects - genetics - physiology |
1 |
|
herpesvirus 8, human - metabolism |
1 |
|
herpesvirus 8, human - physiology |
1 |
|
hodgkin disease - metabolism - virology |
1 |
|
homeostasis |
1 |
|
host adaptation |
1 |
|
host-pathogen interactions |
1 |
|
humanized antibody |
1 |
|
igm |
1 |
|
imaging, three-dimensional |
1 |
|
immediate-early proteins |
1 |
|
immediate-early proteins - biosynthesis - genetics |
1 |
|
immune cells |
1 |
|
immunoassay |
1 |
|
immunogenicity |
1 |
|
immunoglobulin constant regions - genetics |
1 |
|
immunoglobulin variable region - genetics |
1 |
|
in situ hybridization, fluorescence |
1 |
|
influenza a (h1n1) pdm09 virus |
1 |
|
influenza a virus - classification - immunology |
1 |
|
influenza a virus, h1n1 subtype - immunology - pathogenicity |
1 |
|
influenza a virus, h3n2 subtype - immunology |
1 |
|
influenza a virus, h5n1 subtype - chemistry |
1 |
|
influenza a virus, h5n1 subtype - chemistry - genetics - immunology |
1 |
|
influenza a virus, h9n2 subtype - metabolism |
1 |
|
influenza b virus |
1 |
|
influenza diagnosis |
1 |
|
influenza, human |
1 |
|
influenza, human - diagnosis - epidemiology - immunology - virology |
1 |
|
influenza, human - metabolism |
1 |
|
influenza, human - transmission |
1 |
|
integrin |
1 |
|
interleukin-6 - antagonists & inhibitors - metabolism |
1 |
|
k-ras |
1 |
|
keratins - metabolism |
1 |
|
lanthanide-doped upconversion nanoparticles |
1 |
|
leucine zippers |
1 |
|
luminescence resonance energy transfer (lret) |
1 |
|
m6a modification |
1 |
|
magnetic manipulation |
1 |
|
mass spectrometry - methods |
1 |
|
mdck cells |
1 |
|
membrane proteins - genetics - metabolism |
1 |
|
metabolomics |
1 |
|
metastasis |
1 |
|
mf59 |
1 |
|
mice, nude |
1 |
|
microfluidic chip-assisted |
1 |
|
milk proteins |
1 |
|
mir-bart13 |
1 |
|
models, biological |
1 |
|
mortality |
1 |
|
multiplexed detection |
1 |
|
multivariate data analysis |
1 |
|
muscles - cytology |
1 |
|
mutagenesis, site-directed |
1 |
|
mutated peptide |
1 |
|
mutation, missense |
1 |
|
nanocrystalline |
1 |
|
nanospray-ms/ms |
1 |
|
nanotechnology - methods |
1 |
|
nasopharyngeal cancer |
1 |
|
nasopharyngeal neoplasms |
1 |
|
nasopharyngeal neoplasms - metabolism - virology |
1 |
|
nasopharyngeal neoplasms - microbiology |
1 |
|
nb2ctx mxene |
1 |
|
neoplasm proteins |
1 |
|
neoplasm staging |
1 |
|
neutralization therapy |
1 |
|
nf-κb signaling |
1 |
|
nkiras2 |
1 |
|
nucleic acid detection |
1 |
|
nucleoproteins - genetics |
1 |
|
open reading frames |
1 |
|
orthomyxoviridae infections - drug therapy - pathology |
1 |
|
orthomyxoviridae infections - pathology - transmission - veterinary |
1 |
|
paclitaxel - administration & dosage |
1 |
|
pancreatic adenocarcinoma |
1 |
|
pancreatic neoplasms - blood - pathology - therapy |
1 |
|
pandemic (h1n1) 2009 virus |
1 |
|
pandemic h1n1 |
1 |
|
pandemics |
1 |
|
peptide fragments - genetics |
1 |
|
peptides - chemistry |
1 |
|
peptides - chemistry - genetics - immunology |
1 |
|
phosphorylation |
1 |
|
phylogenetic analysis |
1 |
|
pig |
1 |
|
platinum incorporation |
1 |
|
point-of-care |
1 |
|
point-of-care diagnostics |
1 |
|
polymorphism, restriction fragment length |
1 |
|
positive predictive value |
1 |
|
prognosis |
1 |
|
promoter regions (genetics) |
1 |
|
promoter regions (genetics) - physiology |
1 |
|
promoter regions, genetic - genetics |
1 |
|
propagation of virus |
1 |
|
protective immune responses |
1 |
|
protein binding |
1 |
|
protein processing, post-translational - physiology |
1 |
|
protein-tyrosine kinases - metabolism |
1 |
|
proteins - chemistry |
1 |
|
proteomics - methods |
1 |
|
proto-oncogene proteins - blood |
1 |
|
quinazolines - administration & dosage |
1 |
|
radiation |
1 |
|
radiotherapy, conformal |
1 |
|
ras proteins - blood |
1 |
|
receptor binding |
1 |
|
receptor binding site |
1 |
|
receptor specificity |
1 |
|
receptors, notch |
1 |
|
recombinant fusion proteins - biosynthesis |
1 |
|
recombinant fusion proteins - chemistry - genetics - immunology |
1 |
|
recombinant proteins - metabolism |
1 |
|
repressor proteins |
1 |
|
repressor proteins - genetics - metabolism |
1 |
|
restriction mapping |
1 |
|
reverse genetics |
1 |
|
reverse transcriptase polymerase chain reaction |
1 |
|
risk of npc |
1 |
|
rna splicing |
1 |
|
rna, messenger - metabolism |
1 |
|
rna, viral - chemistry - genetics - metabolism |
1 |
|
rnp |
1 |
|
s phase |
1 |
|
safety and toxicity |
1 |
|
sarcoma, kaposi - virology |
1 |
|
screening |
1 |
|
sequence alignment |
1 |
|
sequence homology, nucleic acid |
1 |
|
serological screening |
1 |
|
sh3bp4 |
1 |
|
signal transduction |
1 |
|
spectrometry, mass, electrospray ionization |
1 |
|
spectrometry, mass, electrospray ionization - methods |
1 |
|
stage |
1 |
|
stat1 transcription factor |
1 |
|
stat3 transcription factor |
1 |
|
stat4 transcription factor |
1 |
|
stat5 transcription factor |
1 |
|
sulfonation |
1 |
|
surface-enhanced raman spectroscopy |
1 |
|
survival analysis |
1 |
|
survival rate |
1 |
|
tandem mass spectrometry - methods |
1 |
|
telomere - ultrastructure |
1 |
|
telomeres |
1 |
|
the receptor binding domain of spike |
1 |
|
trans-activation (genetics) |
1 |
|
trans-activators - biosynthesis - genetics |
1 |
|
trans-activators - chemistry - genetics - metabolism |
1 |
|
trans-activators - genetics - metabolism |
1 |
|
trans-activators - metabolism |
1 |
|
transcription, genetic - physiology |
1 |
|
transmissibility |
1 |
|
truncated nucleocapsid protein |
1 |
|
tumor markers, biological - blood |
1 |
|
tumour progression |
1 |
|
two-dimensional gel electrophoresis |
1 |
|
u16-binding protein 4 |
1 |
|
upconversion luminescence |
1 |
|
upconversion nanoparticles |
1 |
|
vaccine |
1 |
|
vaccine mismatch |
1 |
|
viral entry |
1 |
|
viral infections |
1 |
|
viral matrix proteins - chemistry - genetics |
1 |
|
viral matrix proteins - genetics |
1 |
|
viral matrix proteins - genetics - metabolism |
1 |
|
viral mrna splicing |
1 |
|
viral proteins - biosynthesis - genetics |
1 |
|
viral proteins - genetics - metabolism |
1 |
|
viral proteins - physiology |
1 |
|
viral regulatory and accessory proteins - chemistry |
1 |
|
viral rna detection |
1 |
|
virus diagnostics |
1 |
|
virus integration |
1 |
|
virus latency - genetics |
1 |
|
virus titration |
1 |
|
zeolite a synthesis |
1 |
